Search

The main direction proposed by the community of experts in the field of laser-driven ion acceleration is to improve particle beam features (maximum energy, charge, emittance, divergence, monochromaticity, shot-to-shot stability) in order to demonstrate reliable and compact approaches to be used for multidisciplinary applications, thus, in principle, reducing the overall cost of a laser-based facility compared to a conventional accelerator one and, at the same time, demonstrating innovative and more effective sample irradiation geometries. The mission of the laser-driven ion target area at ELI-Beamlines (Extreme Light Infrastructure) in Dolni Břežany, Czech Republic, called ELI Multidisciplinary Applications of laser-Ion Acceleration (ELIMAIA) [1], is to provide stable, fully characterized and tunable beams of particles accelerated by Petawatt-class lasers and to offer them to the user community for multidisciplinary applications. The ELIMAIA beamline has been designed and developed at the Institute of Physics of the Academy of Science of the Czech Republic (IoP-ASCR) in Prague and at the National Laboratories of Southern Italy of the National Institute for Nuclear Physics (LNS-INFN) in Catania (Italy). The key section of the beamline, which includes the beam focusing, the energy selection, the beam transport, the dosimetric and sample irradiation elements, is called ELIMED (ELI MEDical and multidisciplinary applications) [2] portion. At ELIMED, controlled proton and light ion (included carbon) beams up to 300 MeV and 70 AMeV, respectively, can be transported down to the in-air section where absolute dosimetry can be carried out with dose-rate independent devices. A transmission, dual-gap air ionisation chamber provides an on-line measurement of the ion beam dose at the irradiation point, simultaneously allowing for corrections related to ion recombination effects. The maximum expected uncertainty in the final dose released into the user sample is less then 5%. The ELIMED pilot experiment on sample irradiation with laser-accelerated protons is scheduled in 2021. A radiobiological campaign for in-vitro irradiation is planned. In this presentation the status of the ELIMED-ELIMAIA beamline will be reported along with a complete description of its dosimetry systems and their preliminary calibration. The expected final beam characteristics, in terms of dose per pulse, dose-rate and beam spot size (numerically calculated by Monte Carlo simulations) will also be reported. Moreover, an innovative detector based on Silicon Carbide technology capable to reconstruct proton range, energy spectrum, and online released dose will be also discussed. [1] D. Margarone, G.A.P.Cirrone et al., “ELIMAIA: A Laser-Driven Ion Accelerator for Multidisciplinary Applications”, Quantum Beam. Sci., 2, 8 (2018) [2] G.A.P Cirrone, M. Carpinelli et al., “ELIMED, future hadrontherapy applications of laser-accelerated beams”, Nucl. Inst. Meth. 730:174–177 (2013)

The main effort of the laser-driven ion acceleration community is aimed to improve particle beam features (energy, charge, divergence, monochromaticity) and to demonstrate reliable approaches to be used for multidisciplinary applications. An ion acceleration target area based on unique laser capabilities is available at ELI-Beamlines (Extreme Light Infrastructure) in the Czech Republic; it is called ELIMAIA (ELI Multidisciplinary Applications of laser-Ion Acceleration) and aims to provide stable, fully characterized and tuneable beams of particles accelerated by multi-Petawatt-class lasers and to offer them to the user community for multidisciplinary applications. The ELIMAIA section dedicated to ion focusing, selection, characterization and irradiation is named ELIMED (ELI MEDical and multidisciplinary applications). Thanks to ELIMED, very high-dose-rate (around Gy/min) controlled proton and ion beams, with energy ranging from 5 to 250 MeV, will be transported up to an in-air section dedicated to absolute and relative dosimetry of the laser-generated ions. A transmission, dual-gap air ionisation chamber will allow an on-line, non-destructive characterization of the ion dose at the user sample irradiation point. The uncertainty in the final dose released onto the sample is expected to be well below 5$\%$. An ELIMED radiobiology pilot experiment is scheduled in 2021, during which in-vitro cell irradiations will be carried out with well-controlled proton beams. In this work, the status of the ELIMED/ELIMAIA beamline will be reported along with a complete description of the main dosimetric systems and of their calibrations carried out at conventional accelerators.

Significant challenges in the detection of laser-accelerated ions result from the high flux (1010-1012 ions/pulse) and the short bunch duration which are intrinsic to laser-driven sources. The development of diagnostic techniques able to operate in real-time and on a high-rep basis is a key step towards multidisciplinary applications of such non-conventional beams. Real time diagnosis of the main beam parameters for high-energy protons accelerated by the Vulcan Petawatt (VULCAN-PW) laser system has been performed using an on line diagnostics based on the Time of Flight (TOF) technique and the use of diamond detectors. Proton energy spectra have been measured for energies exceeding 30 MeV. The results show that the TOF method employing state-of-the-art detectors is a robust real-time diagnostics, able to operate efficiently under the harsh conditions occurring with kJ-class, PW laser systems, and offering the possibility to monitor on a shot-by-shot basis the main beam parameters of high intensity proton bunches for energies up to the 100 MeV level.

We present preliminary results on generation of energetic α-particles driven by lasers. The experiment was performed at the Institute of Laser Engineering in Osaka using the short-pulse, high-intensity, high-energy, PW-class laser. The laser pulse was focused onto a thin plastic foil (pitcher) to generate a proton beam by the well-known TNSA mechanism which, in turn, was impinging onto a boron-nitride (BN) target (catcher) to generated alpha-particles as a result of proton-boron nuclear fusion events. Our results demonstrate generation of α-particles with energies in the range 8–10 MeV and with a flux around 5 × 10^9 sr^−1.

The ELIMAIA beamline, recently installed at ELI-Beamlines, aims at offering short ion bunches accelerated by high repetition-rate, PW-class lasers to users from multidisciplinary fields by using innovative and compact ion beam transport and dosimetry approaches.

Purpose The main purpose of this work is the inter-comparison between different devices devoted to the transversal dose profile recostruction for daily QA tests in proton therapy. Methods The results obtained with the EBT3 radiochromic films, used as a reference, and other common quality control devices, have been compared with those obtained with a beam profiling system developed at the “Laboratori Nazionali del Sud” of Italian Institute for Nuclear Physics (INFN-LNS, Catania, Italy). It consists of a plastic scintillator screen (thickness 1 mm), mounted perpendicularly to the beam axis and coupled with a highly sensitive CCD detector in a light-tight box. Results and conclusion The tests, carried out both at the INFN-LNS and Trento Proton Therapy Center facilities, show, in general, a good agreement between the different detectors. The beam profiling system, in particular, appears to be a promising quality control device for 2-D relative dosimetry, because of its linear response in a dose rate range useful for proton therapy treatments, its high spatial resolution and its short acquisition and processing time.

The characterisation of a novel multi-strip silicon detector, the serial Dose Magnifying Glass, to incident 60 MeV mono-energetic proton beams, typical for ocular melanoma treatment, was performed by means of Geant4 simulations and experimental methods. Geant4 simulations were performed to determine the applicability and potential of the detector for proton beam range verification with high spatial resolution. Experimental characterisation was performed using the CATANA beam line to confirm the Monte Carlo feasibility study and determine the detector response to incident proton beams of 5 mm, 13 mm, 25 mm and 36 mm diameter, in addition to the detector response when PMMA slabs are positioned between the detector and the beam nozzle. Results indicate the suitability of the detector for proton beam range verification in proton therapy Quality Assurance.

The Bragg Peak is a unique characteristic of ion beams which makes their use beneficial in cancer treatment as it allows the majority of dose deposition to be localised in a precise volume. The use of a laser system for particle acceleration is currently investigated as a potential alternative to the conventional RF accelerators currently used for hadrontherapy. The biological response of cells irradiated by high dose-rate laser-driven ions is currently being explored in this context. The experiment reported here was carried out as part of the A-SAIL project, a UK-wide collaboration aiming to develop innovative techniques for accelerating ions for future clinical applications. In this contest, a radiobiological experiment was carried out on the pico2000 laser beamline at LULI-aEcole Polytechnique using an energetically spread, laser-accelerated proton beam. This paper will discuss the arrangement used in the experiment, and the techniques employed for an accurate estimation of the dose deposited, supported by Monte Carlo simulations of the particle propagation through the irradiation system.

International audience; The Time-of-Flight (TOF) technique coupled with semiconductorlike detectors, as silicon carbide and diamond, is one of the most promising diagnostic methods for high-energy, high repetition rate, laser-accelerated ions allowing a full on-line beam spectral characterization. A new analysis method for reconstructing the energy spectrum of high-energy laser-driven ion beams from TOF signals is hereby presented and discussed. The proposed method takes into account the detector’s working principle, through the accurate calculation of the energy loss in the detector active layer, using Monte Carlo simulations. The analysis method was validated against well-established diagnostics, such as the Thomson parabola spectrometer, during an experimental campaign carried out at the Rutherford Appleton Laboratory (UK) with the high-energy laser-driven protons accelerated by the VULCAN Petawatt laser.

In proton beam therapy, a Spread-Out Bragg peak (SOBP) is used to establish a uniform dose distribution in the target volume. In order to create a SOBP, several Bragg peaks of different ranges, corresponding to different entrance energies, with certain intensities (weights) should be combined each other. In a passive beam scattering system, the beam is usually extracted from a cyclotron at a constant energy throughout a treatment. Therefore, a SOBP is produced by a range modulator wheel, which is basically a rotating wheel with steps of variable thicknesses, or by using the ridge filters. In this study, we used the Geant4 toolkit to simulate a typical passive scattering beam line. In particular, the CATANA transport beam line of INFN Laboratori Nazionali del Sud (LNS) in Catania has been reproduced in this work. Some initial properties of the entrance beam have been checked by benchmarking simulations with experimental data. A class dedicated to the simulation of the wheel modulators has been implemented. It has been designed in order to be easily modified for simulating any desired modulator wheel and, hence, any suitable beam modulation. By using some auxiliary range-shifters, a set of pristine Bragg peaks was obtained from the simulations. A mathematical algorithm was developed, using the simulated pristine dose profiles as its input, to calculate the weight of each pristine peak, reproduce the SOBP, and finally generate a flat dose distribution. Therefore, once the designed modulator has been realized, it has been tested at CATANA facility, comparing the experimental data with the simulation results.

A sealed mini-TEPC able to work in gas-steady modality, a monolithic silicon device composed by a matrix of micrometric cylindrical diodes and a residual energy measurement stage and the silicon MicroPlus Bridge detector were used to perform microdosimetric measurements at the 62 MeV proton clinical SOBP of CATANA at the Southern National Laboratories of INFN (LNS – INFN, Catania, Italy). Measurements were taken at the same different positions in a PMMA phantom, in order to analyse the detector response differences. Finally, a weighting function was applied to the spectra to see if the microdosimetric detectors are able to monitor RBE data for glioma cells (U87) irradiated at six positions along the same modulated 62-MeV proton beam. The results obtained with the three microdosimeters are compared and discussed.

Purpose The aim of this paper is to investigate the limits of LET monitoring of therapeutic carbon ion beams with miniaturized microdosimetric detectors. Methods Four different miniaturized microdosimeters have been used at the 62 MeV/u 12C beam of INFN Southern National Laboratory (LNS) of Catania for this purpose, i.e. a mini-TEPC and a GEM-microdosimeter, both filled with propane gas, and a silicon and a diamond microdosimeter. The y - D (dose-mean lineal energy) values, measured at different depths in a PMMA phantom, have been compared with LET ¯ D (dose-mean LET) values in water, calculated at the same water-equivalent depth with a Monte Carlo simulation setup based on the GEANT4 toolkit. Results In these first measurements, no detector was found to be significantly better than the others as a LET monitor. The y - D relative standard deviation has been assessed to be 13% for all the detectors. On average, the ratio between y - D and LET ¯ D values is 0.9 ± 0.3, spanning from 0.73 ± 0.08 (in the proximal edge and Bragg peak region) to 1.1 ± 0.3 at the distal edge. Conclusions All the four microdosimeters are able to monitor the dose-mean LET with the 11% precision up to the distal edge. In the distal edge region, the ratio of y - D to LET ¯ D changes. Such variability is possibly due to a dependence of the detector response on depth, since the particle mean-path length inside the detectors can vary, especially in the distal edge region.

On the wake of the results obtained so far at the SPARC_LAB test-facility at the Laboratori Nazionali di Frascati (Italy), we are currently investigating the possibility to design and build a new multi-disciplinary user-facility, equipped with a soft X-ray Free Electron Laser (FEL) driven by a ∼ 1 GeV high brightness linac based on plasma accelerator modules. This design study is performed in synergy with the EuPRAXIA design study. In this paper we report about the recent progresses in the on going design study of the new facility. On the wake of the results obtained so far at the SPARC\_LAB test-facility at the Laboratori Nazionali di Frascati (Italy), we are currently investigating the possibility to design and build a new multi-disciplinary user-facility, equipped with a soft X-ray Free Electron Laser (FEL) driven by a $\sim$1 GeV high brightness linac based on plasma accelerator modules. This design study is performed in synergy with the EuPRAXIA design study. In this paper we report about the recent progresses in the on going design study of the new facility.

Within 2017, the ELIMED (ELI-Beamlines MEDical applications) transport beam-line and dosimetric systems for laser-generated beams will be installed at the ELI-Beamlines facility in Prague (CZ), inside the ELIMAIA (ELI Multidisciplinary Applications of laser–Ion Acceleration) interaction room. The beam-line will be composed of two sections: one in vacuum, devoted to the collecting, focusing and energy selection of the primary beam and the second in air, where the ELIMED beam-line dosimetric devices will be located. This paper briefly describes the transport solutions that will be adopted together with the main dosimetric approaches. In particular, the description of an innovative Faraday Cup detector with its preliminary experimental tests will be reported.

A synthetic single crystal diamond based Schottky photodiode was tested at INFN-LNS on the proton beam line (62 MeV) dedicated to the radiation treatment of ocular disease. The diamond detector response was studied in terms of pre-irradiation dose, linearity with dose and dose rate, and angular dependence. Depth dose curves were measured for the 62 MeV pristine proton beam and for three unmodulated range-shifted proton beams; furthermore, the spread-out Bragg peak was measured for a modulated therapeutic proton beam. Beam parameters, recommended by the ICRU report 78, were evaluated to analyze depth-dose curves from diamond detector. Measured dose distributions were compared with the corresponding dose distributions acquired with reference plane-parallel ionization chambers. Field size dependence of the output factor (dose per monitor unit) in a therapeutic modulated proton beam was measured with the diamond detector over the range of ocular proton therapy collimator diameters (5–30 mm). Output factors measured with the diamond detector were compared to the ones by a Markus ionization chamber, a Scanditronix Hi-p Si stereotactic diode and a radiochromic EBT2 film. Signal stability within 0.5% was demonstrated for the diamond detector with no need of any pre-irradiation dose. Dose and dose rate dependence of the diamond response was measured: deviations from linearity resulted to be within 70.5% over the investigated ranges of 0.5–40.0 Gy and 0.3–30.0 Gy/min respectively. Output factors from diamond detector measured with the smallest collimator (5 mm in diameter) showed a maximum deviation of about 3% with respect to the high resolution radiochromic EBT2 film. Depth-dose curves measured by diamond for unmodulated and modulated beams were in good agreement with those from the reference plane-parallel Markus chamber, with relative differences lower than 71% in peak-to-plateau ratios, well within experimental uncertainties. A 2.5% variation in diamond detector response was observed in angular dependence measurements carried-out by varying the proton beam incidence angle in the polar direction. The dosimetric characterization of the tested synthetic single crystal diamond detector clearly indicates its suitability for relative dosimetry in ocular therapy proton beams, with no need of any correction factors accounting for dose rate and linear energy transfer dependence.

Nanostructured and microstructured thin foils have been fabricated and used experimentally as targets to manipulate the spatial profile of proton bunches accelerated through the interaction with high intensity laser pulses (6×10^{19} W/cm^{2}). Monolayers of polystyrene nanospheres were placed on the rear surfaces of thin plastic targets to improve the spatial homogeneity of the accelerated proton beams. Moreover, thin targets with grating structures of various configurations on their rear sides were used to modify the proton beam divergence. Experimental results are presented, discussed, and supported by 3D particle-in-cell numerical simulations.

Laser-accelerated ion beams could represent the future of particle acceleration in several multidisciplinary applications, as for instance medical physics, hadrontherapy and imaging field, being a concrete alternative to old paradigm of acceleration, characterized by huge and complex machines. In this framework, following on from the ELIMED collaboration, launched in 2012 between INFN-LNS and ELI-Beamlines, in 2014 a three-years contract has been signed between the two institutions for the design and the development of a complete transport beam-line for high-energy ion beams (up to 60 MeV) coupled with innovative diagnostics and in-air dosimetry devices. The beam-line will be installed at the ELI-Beamlines facility and will be available for users. The measurement of the beam characteristics, such as energy spectra, angular distributions and dose-rate is mandatory to optimize the transport as well as the beam delivery at the irradiation point. In order to achieve this purpose, the development of appropriate on-line diagnostics devices capable to detect high-pulsed beams with high accuracy, represents a crucial point in the ELIMED beamline development. The diagnostics solution, based on the use of silicon carbide (SiC) and diamond detectors using TOF technique, will be presented together with the preliminary results obtained with laser-accelerated proton beams.

A prototype of proton Computed Tomography (pCT) system for hadron-therapy has been manufactured and tested in a 175 MeV proton beam with a non-homogeneous phantom designed to simulate high-contrast material. BI-SART reconstruction algorithms have been implemented with GPU parallelism, taking into account of most likely paths of protons in matter. Reconstructed tomography images with density resolutions r.m.s. down to ~1% and spatial resolutions

International audience; The system described in this work is meant to be a prototype of a more performing one that will be installed at ELI-Beamlines in Prague for the collection of ions produced after the interaction Laser-target, [2]. It has been realized by the researchers of INFN-LNS (Laboratori Nazionali del Sud of the Instituto Nazionale di Fisica Nucleare) and SIGMAPHI, a French company, using a system of Permanent Magnet Quadrupoles (PMQs), [1]. The final system that will be installed in Prague is designed for protons and carbons up to 60MeV/u, around 10 times more than the energies involved in the present work. The prototype, shown in this work, has been tested in collaboration with the SAPHIR experimental facility group at LOA (Laboratoire d'Optique Applique) in Paris using a 200 TW Ti:Sapphire laser system. The purpose of this work is to validate the design and the performances of this large and compact bore system and to characterize the beam produced after the interaction laser-target and its features. Moreover, the optics simulations have been compared with a real beam shape on a GAF Chromic film. The procedure used during the experimental campaign and the most relevant results are reported here demonstrating a good agreement with the simulations and a good control on the beam optics.

This paper describes the development of a proton Computed Tomography (pCT) apparatus able to reconstruct a map of stopping power useful for accurate proton therapy treatment planning and patient positioning. This system is based on two main components: a silicon microstrip tracker and a YAG:Ce crystal calorimeter. Each proton trajectory is sampled by the tracker in four points: two upstream and two downstream the object under test; the particle residual energy is measured by the calorimeter. The apparatus is described in details together with a discussion on the characterization of the hardware under proton beams with energies up to 175 MeV.

In laser-driven plasma, ion acceleration of aluminum with the production of a quasi-monoenergetic beam has occurred. A useful device to analyze the ions is the Thomson parabolas spectrometer, a well-known diagnostic that is able to obtain information on charge-to-mass ratio and energy distribution of the charged particles. At the LENS (Laser Energy for Nuclear Science) laboratory of INFN-LNS in Catania, experimental measures were carried out; the features of LENS are: Q-switched Nd:YAG laser with 2 J laser energy, 1064 nm fundamental wavelengths, and 6 ns pulse duration.

The Segmented Monolithic Silicon Telescope, a two-stage detector recently proposed as a solid state microdosimeter, demonstrated to be capable of measuring the microdosimetric spectra of clinical proton beams similar to those measured by reference tissue-equivalent proportional counters. This work concerns the study of the possibility of exploiting this feature for carbon beam quality assessment. To this aim, the silicon device was placed in a polymethylmetacrylate phantom and irradiated with a 62 AMeV un-modulated carbon beam at the cyclotron facility of the Laboratori Nazionali del Sud of the Italian Institute of Nuclear Physics. The results of these preliminary measurements will be discussed in details.

In this paper the use of the Filtered Back Projection (FBP) Algorithm, in order to reconstruct tomographic images using the high energy (200–250 MeV) proton beams, is investigated. The algorithm has been studied in detail with a Monte Carlo approach and image quality has been analysed and compared with the total absorbed dose. A proton Computed Tomography (pCT) apparatus, developed by our group, has been fully simulated to exploit the power of the Geant4 Monte Carlo toolkit. From the simulation of the apparatus, a set of tomographic images of a test phantom has been reconstructed using the FBP at different absorbed dose values. The images have been evaluated in terms of homogeneity, noise, contrast, spatial and density resolution.

A YAG(Ce) crystal has been characterized with a proton beam up to 100 MeV. Tests were performed to investigate the possibility of using this detector as a proton calorimeter. A crystal size has been chosen that is able to stop up to 200 MeV. Energy resolution and light response have been measured at Laboratori Nazionali del Sud with a proton beam up to 60 MeV and a spatial homogeneity study of the crystal has been performed at Loma Linda University Medical Center with a 100 MeV proton beam. The YAG(Ce) crystal showed a good energy resolution equal to 3.7% at 60 MeV and measurements, performed in the 30–60 MeV proton energy range, were fitted by Birks' equation. Using a silicon tracker to determine the particle entry point in the crystal, a spatial homogeneity value of 1.7% in the light response has been measured.

A monolithic silicon device consisting of a matrix of micrometric cylindrical diodes (about 2 μm in thickness and 9 μm in diameter) coupled to a residual energy measurement stage E (about 500 μm in thickness) was proposed and studied for assessing the quality of a therapeutic proton beam. The device was placed at different depths inside a polymethyl-methacrylate phantom and irradiated with a modulated 62 MeV proton beam at the Centro di AdroTerapia e Applicazioni Nucleari Avanzate (CATANA) of the Laboratori Nazionali del Sud (LNS, Catania, Italy) of the Istituto Nazionale di Fisica Nucleare (INFN). At each phantom depth, the energy imparted in the two detector stages was measured event-by-event in coincidence mode. The distributions of the energy imparted to the cylindrical diodes were corrected for tissue-equivalence by applying an optimized procedure. In order to perform a comparison with literature data measured with a cylindrical TEPC, the distributions derived with the silicon detector were corrected for shape-equivalence. The agreement with the microdosimetric spectra measured with the TEPC was satisfactory above the detection limit imposed by the electronic noise of the silicon-based system.

ELI (Extreme Light Infrastructure) multidisciplinary applications of laser-ion acceleration (ELIMAIA) is one the user facilities beamlines of the ELI-Beamlines facility in Prague. It will be dedicated to the transport of laser-driven ion beams and equipped with detectors for diagnostics and dosimetry, in order to carry out experiments for a broad range of multidisciplinary applications. One of the aims of the beamline is also to demonstrate the feasibility of these peculiar beams for possible medical applications, which means delivering controllable and stable beams, properly monitoring their transport parameters and accurately measuring the dose per shot. To fulfil this task, innovative systems of charged particle beam diagnostics have been realized and alternative approaches for relative and absolute dosimetry have been proposed. Concerning the first one, real-time diagnostic solutions have been adopted, involving the use of time-of-flight techniques and Thomson parabola spectrometry for an on-line characterization of the ion beam parameters, as well as radiochromic films, nuclear track detectors (typically CR39), and image plates for single shot measurements. For beam dosimetry, real-time beam/dose monitoring detectors have been realized, like the secondary emission monitor and a double-gap ionization chamber, which can be cross calibrated against a Faraday cup, used for absolute dosimetry. The main features of these detectors are reported in this work together with a description of their working principle and some preliminary tests.

Proton imaging is not yet applied as a clinical routine, although its advantages have been demonstrated. In the context of quality assurance in proton therapy, proton images can be used to verify the correct positioning of the patient and to control the range of protons. Proton computed tomography (pCT) is a 3D imaging method appropriate for planning and verification of proton radiation treatments, because it allows evaluating the distributions of proton stopping power within the tissues and can be directly utilized when the patient is in the actual treatment position. The aim of the PRoton IMAging experiment, supported by INFN, and the PRIN 2006 project, supported by MIUR, is to realize a proton computed radiography (pCR) prototype for reconstruction of proton images from a single projection in order to validate the technique with pre-clinical studies and, eventually, to conceive the configuration of a complete pCT system. A preliminary experiment performed at the 250 MeV proton synchrotron of Loma Linda University Medical Center (LLUMC) allowed acquisition of experimental data before the completion of PRIMA project's prototype. In this paper, the results of the LLUMC experiment are reported and the reconstruction of proton images of two phantoms is discussed.

Proton radiation therapy is a precise form of cancer therapy, which requires verification of the patient position and the accurate knowledge of the dose delivered to the patient. At present in the proton treatment centre, patients are positioned with X-ray radiography and dose calculations rely on the patient's morphology and electron densities obtained by X-ray computed tomography [U. Schneider, E. Pedroni, Med. Phys. 22 (1995) 353]. A proton imaging device can improve the accuracy of proton radiation therapy treatment planning and the alignment of the patient with the proton beam. Our collaboration has developed a pCR prototype consisting of a silicon microstrip tracker and a calorimeter to detect the residual energy [R. Shulte, et al., IEEE Trans. Nucl. Sci. 51 (2004) 866–872]. In this contribution we will show some results obtained testing the front-end board of the tracker and measurements performed at LNS (Laboratori Nazionali del Sud) and in LLUMC (Loma Linda University Medical Centre) using 60 and 200 MeV proton beams to test the calorimeter.

Due to the features of the modern radiotherapy techniques, namely intensity modulated radiation therapy and proton therapy, where high spatial dose gradients are often present, detectors to be employed for 2D dose verifications have to satisfy very narrow requirements. In particular they have to show high spatial resolution. In the framework of the European Integrated Project—Methods and Advanced Equipment for Simulation and Treatment in Radio-Oncology (MAESTRO, no. LSHC-CT-2004-503564), a dosimetric detector adequate for 2D pre-treatment dose verifications was developed. It is a modular detector, based on a monolithic silicon-segmented sensor, with an n-type implantation on an epitaxial p-type layer. Each pixel element is 2×2 mm 2 and the distance center-to-center is 3 mm. The sensor is composed of 21×21 pixels. In this paper, we report the dosimetric characterization of the system with a proton beam. The sensor was irradiated with 62 MeV protons for clinical treatments at INFN-Laboratori Nazionali del Sud (LNS) Catania. The studied parameters were repeatability of a same pixel, response linearity versus absorbed dose, and dose rate and dependence on field size. The obtained results are promising since the performances are within the project specifications.

A detector to monitor online the protontherapy beam at the Istituto Nazionale di Fisica Nucleare (INFN), Laboratori Nazionali del Sud (LNS) has been built and characterized. The detector is made of two ionization chambers: each chamber has the anode splitted into 256 0.5 mm strips with vertical and horizontal orientation. The chambers are part of the beam line: signals can be processed online at a speed up to 100 Hz and results are promptly available. Thus the beam geometry can be controlled continuously during patient treatment, and in case of deviation from the required conditions, the treatment can be directly concluded.

In this paper we report on a new powerful and self-consistent analysis technique aimed in order to get information online on laser generated plasmas. Performance of the method has been carried out during two set of measurement by using two different lasers. The first set of data has been collected at LENS Laboratory of INFN-LNS in Catania by using a laser which produces pulses having energies of 2 J and temporal duration of 6 ns, while the second set of data has been collected at ILIL of INO-CNR in Pisa with a laser system capable of delivering pulses of up to 10 mJ in 40 fs.

The design and the characterization of a calorimeter system, aimed at measuring the residual energy in a proton Computed Tomography (pCT) apparatus, is described. The calorimeter has a 6 × 6 cm2 active area to fully cover the tracker area of the pCT system, being 10 cm thick it is able to stop up to 200 MeV protons and sustain 1 MHz particle rate (average rate on the whole area). The YAG(Ce) scintillator is promising for charged particle detection applications where high-count rate, good energy resolution and compact photodiode readout, not influenced by magnetic fields, are of importance. The aim of this work is to show data acquired with proton beam energy up to 175 MeV and to discuss the performances of this calorimeter.

Preliminary results are presented from a test of a parallel plate ionization chamber with the anode segmented in strips (MOPI) to be used as a beam monitor for therapeutical treatments on the 62 MeV proton beam line of the INFN-LNS Superconducting Cyclotron. Ocular pathologies have been treated at the Catana facility since March 2002. The detector, placed downstream of the patient collimator, will allow the measurement of the relevant beam diagnostic parameters during treatment such as integrated beam fluence, for dose determination; the beam baricentre, width and asymmetry will be obtained from the fluence profile sampled with a resolution of about 100 Urn at a rate up to 1 kHz with no dead time. In this test, carried out at LNS, the detector has been exposed to different beam shapes and the integrated fluence derived by the measured beam profiles has been compared with that obtained with other dosimeters normally used for treatment. The skewness of the beam profile has been measured and shown to be suitable to on-line check variations of the beam shape.

A facility in which a 62 MeV proton beam is employed in the radiotherapeutic treatment of several ocular disease has been active since March 2002 at Laboratori Nazionali del Sud. A fast and accurate quality control system of such beam has been designed and tested. The system consists of a scintillating screen mounted perpendicularly to the beam axis at a fixed distance and observed by a highly sensitive charge-coupled device camera. The basic idea is the possibility to obtain real time information about the relative spatial dose distribution delivered to tissue through the measurement of the light emission in the scintillating screen. A comparison with the presently used dosimetric system (a motorized silicon diode) that, in the future, will be replaced by the device introduced in this paper (if its experimental performance will be successful) has been carried out. The good capabilities of the system make it worthy of further investigations into its applicability in proton beams monitoring for radiotherapeutic treatments (i.e., reconstruction of depth dose distribution and beam monitoring during patient irradiation).

The aim of this work was to test the suitability of a PTW diamond detector for nonreference condition dosimetry in photon beams of different energy (6 and 25 MV) and field size (from 2.6 cm x 2.6 cm to 10 cm x 10 cm). Diamond behavior was compared to that of a Scanditronix p-type silicon diode and a Scanditronix RK ionization chamber. Measurements included output factors (OF). percentage depth doses (PDD) and dose profiles. OFs measured with diamond detector agreed within 1% with those measured with diode and RK chamber. Only at 25 MV, for the smallest field size, RK chamber underestimated OFs due to averaging effects in a pointed shaped beam profile. Agreement was found between PDDs measured with diamond detector and RK chamber for both 6 MV and 25 MV photons and down to 5 cm x 5 cm field size. For the 2.6 cm x 2.6 cm field size, at 25 MV, RK chamber underestimated doses at shallow depth and the difference progressively went to zero in the distal region. PDD curves measured with silicon diode and diamond detector agreed well for the 25 MV beam at all the field sizes. Conversely, the nontissue equivalence of silicon led, for the 6 MV beam, to a slight overestimation of the diode doses in the distal region, at all the field sizes. Penumbra and field width measurements gave values in agreement for all the detectors but with a systematic overestimate by RK measurements. The results obtained confirm that ion chamber is not a suitable detector when high spatial resolution is required. On the other hand, the small differences in the studied parameters, between diamond and silicon systems, do not lead to a significant advantage in the use of diamond detector for routine clinical dosimetry.

The dosimetric properties of two PTW Riga diamond detectors type 60003 were studied in high-energy photon and electron therapy beam. Properties under study were current-voltage characteristic, polarization effect, time stability of response, dose response, dose-rate dependence, temperature stability, and beam quality dependence of the sensitivity factor. Differences were shown between the two detectors for most of the previous properties. Also, the observed behavior was, to some extent, different from what was reported in the PTW technical specifications. The necessity to characterize each diamond detector individually was addressed.

The scientific community has shown a growing interest towards multidisciplinary applications of laser-driven beams. In this framework, the ELIMED (ELI-Beamlines MEDical and multidisciplinary applications) beamline will be the first transport beamline dedicated to the medical and multidisciplinary studies with laser-accelerated ion beams. Detectors for dosimetry represent one of key-element of the ELIMED beamline, allowing a dose delivering with good result as required in the clinical applications. In this contribution, a Faraday Cup for absolute dosimetry, designed and realized at INFN-LNS, is described.

Nano and micro structured thin (μ m-scale) foils were designed, fabricated and irradiated with the high intensity laser system operating at LLC (Lund Laser Centre, Sweden) in order to systematically study and improve the main proton beam parameters. Nano-spheres deposited on the front (laser irradiated) surface of a flat Mylar foil enabled a small enhancement of the maximum energy and number of the accelerated protons. Nano-spheres on the rear side allowed to modify the proton beam spatial profile. In particular, with nanospheres deposited on the rear of the target, the proton beam spatial homogeneity was clearly enhanced. Silicon nitride thin foils having micro grating structures (with different step dimensions) on the rear surface were also used as targets to influence the divergence of the proton beam and drastically change its shape through a sort of stretching effect. The target fabrication process used for the different target types is described, and representative experimental results are shown and discussed along with supporting 3D particle-in-cell simulations.

The OFFSET collaboration aims at the development of a novel system for tracking charged particles, designed to achieve real-time imaging, large detection areas, and a high spatial resolution especially suitable for use in medical diagnostics. This paper presents the first prototype of this tracker, having a 20×20 cm2 sensitive area made by two crossed ribbons of 500 μ m square scintillating fibers. The track position information is extracted in real time using a reduced number of read-out channels to obtain very large detection area at moderate cost and complexity. The performance of the tracker was investigated using β sources, cosmic rays and a 62 MeV proton beam.

Nowadays, laser-driven proton beams generated by the interaction of high power lasers with solid targets represent a fascinating attraction in the field of the new acceleration techniques. These beams can be potentially accelerated up to hundreds of MeV and, therefore, they can represent a promising opportunity for medical applications. Laser-accelerated proton beams typically show high flux (up to 1011 particles per bunch), very short temporal profile (ps), broad energy spectra and poor reproducibility. In order to overcome these limitations, these beams have be controlled and transported by means of a proper beam handling system. Furthermore, suitable dosimetric diagnostic systems must be developed and tested. In the framework of the ELIMED project, we started to design a dedicated beam transport line and we have developed a first prototype of a beam line key-element: an Energy Selector System (ESS). It is based on permanent dipoles, capable to control and select in energy laser-accelerated proton beams. Monte Carlo simulations and some preliminary experimental tests have been already performed to characterize the device. A calibration of the ESS system with a conventional proton beam will be performed in September at the LNS in Catania. Moreover, an experimental campaign with laser-driven proton beam at the Centre for Plasma Physics, Queens University in Belfast is already scheduled and will be completed within 2014.

Thomson Spectrometers (TPs) are widely used for beam diagnostic as they provide simultaneous information on charge over mass ratio, energy and momentum of detected ions. A new TP design has been realized at INFN-LNS within the LILIA (Laser Induced Light Ion Acceleration) and ELIMED (MEDical application at ELI-Beamlines) projects. This paper reports on the construction details of the TP and on its experimental tests performed at PALS laboratory in Prague, with the ASTERIX IV laser system. Reported data are obtained with polyethylene and polyvinyl alcohol solid targets, they have been compared with data obtained from other detectors. Consistency among results confirms the correct functioning of the new TP. The main features, characterizing the design, are a wide acceptance of the deflection sector and a tunability of the, partially overlapping, magnetic and electric fields that allow to resolve ions with energy up to about 40 MeV for protons.

A high energy resolution, high dispersive power Thomson Parabola Spectrometer has been developed at INFN-LNS in order to characterize laser-driven beams up to 30- 40 MeV for protons. This device has parallel electric and magnetic field to deflect particles of a certain charge-to-mass ratio onto parabolic traces on the detection plane. Calibration of the deflection sector is crucial for data analysis, namely energy determination of analysed beam, and to evaluate the effective energy limit and resolution. This work reports the study of monochromatic proton beams delivered by the TANDEM accelerator at LNS (Catania) in the energy range between 6 and 12.5 MeV analysed with our spectrometer which allows a precise characterization of the electric and magnetic deflections. Also the energy and the Q/A resolutions and the energy limits have been evaluated proposing a mathematical model that can be used for data analysis, for the experimental set up and for the device scalability for higher energy.

In this paper we describe a new detection system for the high resolution measurement of the residual range of charged particles, designed and developed with the aim of achieving real-time data acquisition and large detection areas. A prototype of the residual range detector, with a sensitive area of about 4 × 4 cm2, consisting of a stack of sixty ribbons of scintillating fibers (Sci-Fi) has been designed and tested. Each layer is read-out by two wavelength shifter (WLS) fibers and a position sensitive photomultiplier (PSPM). The Bragg peak shape is calculated real-time by the time over a suitable threshold for each channel. The results of the measurements taken using the prototype and a 62 MeV proton beam and a comparison with the GEANT4 simulations of the detector are presented. The main concepts on which the prototype is based have been used to demonstrate the technique patented by the INFN. The next step will be to design and validate the final detector which will have 30 × 30 cm2 FOV and cover the 250 MeV proton range with about 150 micron range resolution. These performances are suitable for almost all medical imaging applications.

The design of a detector for tracking charged particles is presented together with the characterization techniques developed to extract the main design specifications. The goals for the final detector are to achieve real-time imaging performances, a large detection area, and a high spatial resolution, particularly suitable for medical imaging applications. This paper describes the prototype of the tracker plane, which has a 20 × 20 cm2sensitive area consisting of two crossed ribbons of 500 μm square scintillating fibers. The information about the hit position extracted real-time tracker in an innovative way, using a reduced number of the read-out channels to obtain a very large detection area but with moderate costs and complexity. The performances of the tracker have been investigated usingβsources, cosmic rays, and a 62 MeV proton beam.

Proton therapy can overcome the limitations of conventional radiotherapy due to the more selective energy deposition in depth and to the increased biological effectiveness. Verification of the delivered dose is desirable, but the complete stopping of the protons in patient prevents the application of electronic portal imaging methods that are used in conventional radiotherapy During proton therapy β + emitters like 11 C, 15 O, 10 C are generated in irradiated tissues by nuclear reactions. The measurement of the spatial distribution of this activity, immediately after patient irradiation, can lead to information on the effective delivered dose. First, results of a feasibility study of an in-beam PET for proton therapy are reported. The prototype is based on two planar heads with an active area of about 5×5 cm 2 . Each head is made up of a position sensitive photomultiplier coupled to a square matrix of same size of LYSO scintillating crystals (2×2×18 mm 3 pixel dimensions). Four signals from each head are acquired through a dedicated electronic board that performs signal amplification and digitization. A 3D reconstruction of the activity distribution is calculated using an expectation maximization algorithm. To characterize the PET prototype, the detection efficiency and the spatial resolution were measured using a point-like radioactive source. The validation of the prototype was performed using 62 MeV protons at the CATANA beam line of INFN LNS and PMMA phantoms. Using the full energy proton beam and various range shifters, a good correlation between the position of the activity distal edge and the thickness of the beam range shifter was found along the axial direction.

Hadron therapy for tumor treatment is nowadays used in several medical centres. The main advantage in using protons or light ions beams is the possibility of tightly shaping the radiation dose to the target volume. Presently the spatial accuracy of the therapy is limited by the uncertainty in stopping power distribution, which is derived, for each treatment, from the photon attenuation coefficients measured by X-ray tomography. A direct measurement of the stopping powers will help in reducing this uncertainty. This can be achieved by using a proton beam and a detection system able to reconstruct a tomography image of the patient. As a first step towards such a system an apparatus able to perform a proton transmission radiography (pCR) has been designed. It consists of a silicon microstrip tracker, measuring proton trajectories, and a YAG:Ce calorimeter to determine the particle residual energy. Proton beam and laboratory tests have been performed on the system components prototypes: the main results will be shown and discussed.

During particle therapy irradiation, positron emitters with half-lives ranging from 2 to 20 min are generated from nuclear processes. The half-lives are such that it is possible either to detect the positron signal in the treatment room using an in-beam positron emission tomography (PET) system, right after the irradiation, or to quickly transfer the patient to a close PET/CT scanner. Since the activity distribution is spatially correlated with the dose, it is possible to use PET imaging as an indirect method to assure the quality of the dose delivery. In this work, we present a new dedicated PET system able to operate in-beam. The PET apparatus consists in two 10 cm × 10 cm detector heads. Each detector is composed of four scintillating matrices of 23 × 23 LYSO crystals. The crystal size is 1.9 mm × 1.9 mm × 16 mm. Each scintillation matrix is read out independently with a modularized acquisition system. The distance between the two opposing detector heads was set to 20 cm. The system has very low dead time per detector area and a 3 ns coincidence window, which is capable to sustain high single count rates and to keep the random counts relatively low. This allows a new full-beam monitoring modality that includes data acquisition also while the beam is on. The PET system was tested during the irradiation at the CATANA (INFN, Catania, Italy) cyclotron-based proton therapy facility. Four acquisitions with different doses and dose rates were analysed. In all cases the random to total coincidences ratio was equal or less than 25%. For each measurement we estimated the accuracy and precision of the activity range on a set of voxel lines within an irradiated PMMA phantom. Results show that the inclusion of data acquired during the irradiation, referred to as beam-on data, improves both the precision and accuracy of the range measurement with respect to data acquired only after irradiation. Beam-on data alone are enough to give precisions better than 1 mm when at least 5 Gy are delivered.

Thomson Parabola (TP) spectrometers are widely used devices for laser-driven beam diagnostics as they provide a complete set of information on the accelerated particles. A novel TP has been developed at LNS with a design able to detect protons up to 20 MeV. The layout design and some results obtained during the experimental campaign at PALS laboratory will be reported in the following.

The definition of detectors, methods and procedures for the absolute and relative dosimetry of laser-driven proton beams is a crucial step toward the clinical use of this new kind of beams. Hence, one of the ELIMED task, will be the definition of procedures aiming to obtain an absolute dose measure at the end of the transport beamline with an accuracy as close as possible to the one required for clinical applications (i.e. of the order of 5% or less). Relative dosimetry procedures must be established, as well: they are necessary in order to determine and verify the beam dose distributions and to monitor the beam fluence and the energetic spectra during irradiations. Radiochromic films, CR39, Faraday Cup, Secondary Emission Monitor (SEM) and transmission ionization chamber will be considered, designed and studied in order to perform a fully dosimetric characterization of the ELIMED proton beam.